Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Catherine V. Barker"'
Autor:
Bruce A. Julian, Robert J. Wyatt, Catherine V. Barker, Susan Y. Woodford, Richard P. Lifton, Ali G. Gharavi, Jan Novak, Jiri Mestecky, Zina Moldoveanu
Publikováno v:
Journal of the American Society of Nephrology. 19:1008-1014
IgA nephropathy (IgAN) is a complex trait determined by genetic and environmental factors. Most IgAN patients exhibit a characteristic undergalactosylation of the O-glycans of the IgA1 hinge region, which promotes formation and glomerular deposition
Autor:
Josef T. Prchal, Tomas Stopka, Roman R. Brantley, Bruce A. Julian, John J. Curtis, Catherine V. Barker, Jeannette Y. Lee, Robert S. Gaston
Publikováno v:
Journal of the American Society of Nephrology. 9:1104-1108
The mechanism by which angiotensin-converting enzyme inhibitors reduce red cell mass in renal transplant recipients with erythrocytosis is unclear. To examine the role of angiotensin II in this disorder, losartan (a competitive antagonist of the angi
Autor:
Robert S. Gaston, Catherine V. Barker, David G. Warnock, Curtis Jj, Shirley Schlessinger, Paul W. Sanders
Publikováno v:
Journal of the American Society of Nephrology. 5:1426-1433
To evaluate the association of cyclosporine (CsA)-related nephrotoxicity with nitric oxide (NO) and endothelin, the effects of L-arginine (LA) and branched-chain amino acid (BCAA) infusions on renal hemodynamics in 5 normal volunteers and 12 renal tr
Autor:
Gerald Krystal, Bruce A. Julian, John J. Curtis, Robert S. Gaston, Catherine V. Barker, Arnold G. Diethelm
Publikováno v:
Kidney International. 46(5):1397-1403
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Enalapril effectively decreases hematocrits in patients with postrenal transplant erythrocytosis (PTE). We studied the effect of enalapril withdrawal on erythropoiesis in
Autor:
Arun Chandrakantan, Piti Ratanapanichkich, Mowaffaq Said, Bruce A. Julian, Catherine V. Barker
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 20(6)
Background. Transplantation offers an excellent option for patients with immunoglobulin-A nephropathy (IgAN) with severe renal dysfunction. However, IgAN frequently recurs in allografts treated with azathioprine. We examined the impact of mycophenola
Autor:
Ali G. Gharavi, Robert J. Wyatt, Catherine V. Barker, K.A. Lavigne, Bruce A. Julian, Jan Novak, Susan Y. Woodford, Zina Moldoveanu
Publikováno v:
Scopus-Elsevier
Background: Two decades ago, pedigrees of patients with IgA nephropathy (IgAN) from Pike County, KY, USA, provided evidence for a role of genetic factors in the pathogenesis of this disorder. Subsequently additional pedigrees were described for sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56513c5405ac5ea1de5364371fe2733e
http://www.scopus.com/inward/record.url?eid=2-s2.0-76649084552&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-76649084552&partnerID=MN8TOARS